In vitro excess ammonia production in human myeloma cell lines

Leukemia

Volumn 12, Issue 7, 1998, Pages 1149-1158

  Otsuki, T ^a   Yamada, O ^a   Sakaguchi, H ^a   Ichiki, T ^a   Kouguchi, K ^a   Wada, H ^a   Hata, H ^b   Yawata, Y ^a   Ueki, A ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Cell line; Enzyme; Hyperammonemia; Myeloma; RT PCR

Indexed keywords

AMMONIA;

AMINO ACID BLOOD LEVEL; AMMONIA FORMATION; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; HYPERAMMONEMIA; LIVER CARCINOMA; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031872933     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401077     Document Type: Article

References (12)

1. Oken MM. Multiple myeloma: prognosis and standard treatment. Cancer Invest 1997; 15: 57-64.
2. Bjorkstrand B. Multiple myeloma, high-dose treatment and autologous stem cell transplantation - current status. Med Oncol 1996; 13: 23-30.
3. Zulian GB. Multiple myeloma: clinical evaluation of plasma cell lymphoproliferative disorders and initial management. Semin Hematol 1997; 34 (Suppl. 1): 29-39.
4. Blade J, San-Miguel IF, Fontanillas M, Alcala A, Maldonado J, Carcia-Conde J, Conde E, Conzalez-Brito G, Moro MJ, Escudero ML, Trujillo J, Pascual A, Rozman C, Estape J, Montserrat E. Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/autotransplantation and who were conventionally treated. J Clin Oncol 1996; 14: 2167-2173.
5. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, Casassus P, Maisonneuve H, Facon T, Ifrah N, Payen C, Bataille R. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. New Engl J Med 1996; 335: 91-97.
6. Grignani G, Gobbi PG, Formisano R, Pieresca C, Ucci G, Brugnatelli S, Riccardi A, Ascari E. A prognostic index for multiple myeloma. Br I Cancer 1996; 73: 1101-1107.
7. Bloemendal HJ, Lobatto S. Hyperamylasaemia in multiple myeloma. Neth J Med 1996; 49: 38-41.
8. Lopez J, Ulibarrena C, Gonzalez-Porque P, Navas G, Roldan E, Cancelas JA, Perez-Oteyza J, Burgaleta C, Garcia-Larana J, Sastre JL, Brieva JA, Odriozola J, Navarro JL. Amylase-producing Bence Jones multiple myeloma with pancreatitis-like symptoms. Acta Haematol 1993; 90: 99-101.
9. Delannoy A, Hamels J, Mecucci C, Fally P, Wallef G, de-Fooz C, Carlier B. Amylase-producing IgD-type multiple myeloma. J Intern Med 1992; 232: 457-460.
10. Moriyama T, Tozawa T, Yamashita H, Onodera S, Nobuoka M, Makino M. Separation and characterization of sialic acid-containing salivary-type amylase from patients' sera with immunoglobulin A-type myeloma. J Chromatogr 1991; 571: 61-72.
11. Fujii H, Yashige H, Kanoh T, Urata Y. Amylase-producing multiple myeloma. Arch Pathol Lab Med 1991; 115: 952-956.
12. Wada H, Ohtsuki T, Sugihara T, Ata K, Hashimoto M, Yamada O, Yawata Y, Manabe T, Miyamoto K. Ectopic production of amylase by a non-producing type of multiple myeloma. Jpn J Clin Hematol 1990; 31: 1022-1027.